Vancouver, British Columbia, Canada, December 15, 2020 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis platform, today announced the launch of Efixii, its medical cannabis efficacy consumer-app; continuing its focus on the benefits that efficacy-truths bring to the Canadian medical cannabis and adult-use markets, which are forecast to grow to CA$4.1 billion in 20211.
The new Efixii app provides numerous free services to consumers as well as premium subscription services. Prices start at $0.99 per month for a single, personalized cannabis efficacy report for a patient. Prices increase for medical cannabis efficacy trend analyses or AI-driven product guidance based on a patient's symptoms. All in-app premium reports are based on the Efixii lifecycle-data that the GCAC platform acquired from cultivators, labs. and consumers. To bring medical cannabis consumption to the next level, GCAC delivers a suite of seed to sale cannabis lifecycle attestation technologies. The new Efixii app is a consumer view leveraging GCAC's proprietary big-data set. Valuable lifecycle details such as mother plant genomic sequence, and advanced batch-to-batch comparisons, serve to enhance medical cannabis reproducibility and deliver trustworthy efficacy results that patients can rely on when deciding to medicate with cannabis.
GCAC's CEO, Brad Moore: "We're excited to break cover and commercially launch Efixii as the premier medical cannabis efficacy platform. Over the last four years, we have established GCAC as one of the most exclusive, results-driven medical cannabis technologies in Canada and beyond. The launch of our new online business will propel our platform to the next level. We are now focussed on an intensive marketing campaign to attract medical cannabis growers so they can provide truthful cannabis lifecycle data to their consumers by using the GCAC suite of technologies. Over the next 12 months, we have set an achievable goal of attracting 10 new growers cultivating 34 million grams of cannabis with an Efixii QR code on each packaged gram. We believe that this means over 110,000 subscribers will have access to better medical cannabis products, creating better patient outcomes."
All Efixii medical cannabis efficacy contributions remain the intellectual property ("IP") of GCAC. Securing GCAC's IP creates an inherent difficulty in replicating, or directly competing with, GCAC's medical cannabis datasets and technology solutions. The company believes this makes GCAC one of the most complete and exciting efficacy platforms in the cannabis space.[1]
About Global Compliance Applications Corp.
Global Compliance Applications Corp. is a global leader in designing and developing innovative blockchain technologies and machine learning solutions to improve real-world businesses.
Contact details
Related topics
Related news
GCAC Partners with Wholesaler Varied State to Offer CBD Brands Access to Wholesale and Direct to Retail Services
GCAC is helping its Efixii Uplift clients gain access to additional sales channels through Varied State.
GCAC Breaks New Ground with Efixii Uplift Coupons on the ROKU Network
GCAC is excited to partner with W and W Digital LLC (“WWTV”), a major ROKU-connected TV network, and present CBD and cannabis NFT coupons to a wider audience streaming content to their computer or ...
GCAC Partners with Cannabis Life Science to Bring Discounted Cannabis to Nevada’s 200k Veterans
Global Compliance Applications Corp. is excited to partner with Cannabis Life Sciences (“CLS”), CLS Holdings USA, Inc.
GCAC’s Efixii Uplift App Hits Unprecedented 2200% Growth in Downloads
GCAC's innovative app, Efixii Uplift, has seen an extraordinary surge in popularity, with download numbers crossing the 2000 mark on both iOS and Android platforms.
GCAC and HempHoney: Pioneering a Healthier CBD Future for Veterans
GCAC is proud to announce a strategic partnership with HempHoney, the creators of the world's finest CBD-infused honey.